355 related articles for article (PubMed ID: 8039126)
1. The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa primitive neuroectodermal tumors.
Kao GD; Goldwein JW; Schultz DJ; Radcliffe J; Sutton L; Lange B
Cancer; 1994 Aug; 74(3):965-71. PubMed ID: 8039126
[TBL] [Abstract][Full Text] [Related]
2. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.
Ris MD; Packer R; Goldwein J; Jones-Wallace D; Boyett JM
J Clin Oncol; 2001 Aug; 19(15):3470-6. PubMed ID: 11481352
[TBL] [Abstract][Full Text] [Related]
3. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.
Fouladi M; Chintagumpala M; Laningham FH; Ashley D; Kellie SJ; Langston JW; McCluggage CW; Woo S; Kocak M; Krull K; Kun LE; Mulhern RK; Gajjar A
J Clin Oncol; 2004 Nov; 22(22):4551-60. PubMed ID: 15542806
[TBL] [Abstract][Full Text] [Related]
4. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
Kumar P; Mulhern RK; Regine WF; Rivera GK; Kun LE
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):561-6. PubMed ID: 7852120
[TBL] [Abstract][Full Text] [Related]
5. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma).
Goldwein JW; Radcliffe J; Johnson J; Moshang T; Packer RJ; Sutton LN; Rorke LB; D'Angio GJ
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):899-904. PubMed ID: 8598368
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.
Mulhern RK; Palmer SL; Merchant TE; Wallace D; Kocak M; Brouwers P; Krull K; Chintagumpala M; Stargatt R; Ashley DM; Tyc VL; Kun L; Boyett J; Gajjar A
J Clin Oncol; 2005 Aug; 23(24):5511-9. PubMed ID: 16110011
[TBL] [Abstract][Full Text] [Related]
7. Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study.
Sawamura Y; Ikeda J; Ishii N; Kato T; Tada M; Abe H; Shirato H
Neurol Med Chir (Tokyo); 1996 Sep; 36(9):632-8. PubMed ID: 8913079
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of dietetic intervention in children with medulloblastoma or supratentorial primitive neuroectodermal tumors.
Bakish J; Hargrave D; Tariq N; Laperriere N; Rutka JT; Bouffet E
Cancer; 2003 Sep; 98(5):1014-20. PubMed ID: 12942570
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy.
Câmara-Costa H; Resch A; Kieffer V; Lalande C; Poggi G; Kennedy C; Bull K; Calaminus G; Grill J; Doz F; Rutkowski S; Massimino M; Kortmann RD; Lannering B; Dellatolas G; Chevignard M;
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):978-985. PubMed ID: 26194675
[TBL] [Abstract][Full Text] [Related]
10. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
[TBL] [Abstract][Full Text] [Related]
11. Intellectual impairment after treatment for medulloblastoma and astrocytoma in childhood: the Brazilian experience.
Hazin I; Dellatolas G; Garcia D; Pedrosa F; Pedrosa A
J Pediatr Hematol Oncol; 2011 Oct; 33(7):506-15. PubMed ID: 21941143
[TBL] [Abstract][Full Text] [Related]
12. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
[TBL] [Abstract][Full Text] [Related]
13. Possible association between the integrity of cerebellar pathways and neurocognitive performance in children with posterior fossa tumors.
Liguoro I; Passone E; Zilli T; Maieron M; De Colle MC; Skrap M; Dolcemascolo V; Sommariva G; Cogo P; Tomasino B
Pediatr Blood Cancer; 2020 Sep; 67(9):e28538. PubMed ID: 32652734
[TBL] [Abstract][Full Text] [Related]
14. Management of children with primitive neuroectodermal tumors of the posterior fossa/medulloblastoma.
Packer RJ; Sutton LN; D'Angio G; Evans AE; Schut L
Pediatr Neurosci; 1985-1986; 12(4-5):272-82. PubMed ID: 3039477
[TBL] [Abstract][Full Text] [Related]
15. Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage.
Grill J; Viguier D; Kieffer V; Bulteau C; Sainte-Rose C; Hartmann O; Kalifa C; Dellatolas G
J Neurosurg; 2004 Nov; 101(2 Suppl):152-8. PubMed ID: 15835102
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-year results.
Packer RJ; Sutton LN; Atkins TE; Radcliffe J; Bunin GR; D'Angio G; Siegel KR; Schut L
J Neurosurg; 1989 May; 70(5):707-13. PubMed ID: 2709111
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in children with primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa.
Packer RJ; Sposto R; Atkins TE; Sutton LN; Bruce DA; Siegel KR; Rorke LB; Littman PA; Schut L
Pediatr Neurosci; 1987; 13(4):169-75. PubMed ID: 3454439
[TBL] [Abstract][Full Text] [Related]
18. Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis.
Palmer SL; Goloubeva O; Reddick WE; Glass JO; Gajjar A; Kun L; Merchant TE; Mulhern RK
J Clin Oncol; 2001 Apr; 19(8):2302-8. PubMed ID: 11304784
[TBL] [Abstract][Full Text] [Related]
19. Persistent cognitive dysfunction secondary to cerebellar injury in patients treated for posterior fossa tumors in childhood.
Rønning C; Sundet K; Due-Tønnessen B; Lundar T; Helseth E
Pediatr Neurosurg; 2005; 41(1):15-21. PubMed ID: 15886508
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic schedules influence the pattern of intellectual decline after irradiation of posterior fossa tumors.
Kieffer-Renaux V; Viguier D; Raquin MA; Laurent-Vannier A; Habrand JL; Dellatolas G; Kalifa C; Hartmann O; Grill J
Pediatr Blood Cancer; 2005 Nov; 45(6):814-9. PubMed ID: 15924360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
